A Study of ATI-50002 Topical Solution for the Treatment of Alopecia Areata

Summary

Primary: • To assess safety, tolerability and efficacy of 2 dose strengths of ATI-50002 Topical Solution, compared to vehicle in subjects with alopecia areata (AA) Secondary: • To evaluate key clinical outcome assessments

Timeline

Start

2017-11-29

Primary completion

2019-04-18

Completion

2019-09-10

Outcome

Outcome not reported

Stopped: “The double-blind primary endpoint was not met. Open Label Extension period halted as a result.”

Drugs

Indications